Waltermire Robert E.'s Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed Dec 18, 2023
- Accession no.
- 0000950170-23-071116
- Filed
- Dec 18, 2023
- Trade date
- Dec 14-15, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $942.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Waltermire Robert E.CIK 0001876996 | Officer (Senior VP, Chief Pharma Dev.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Stock | MOption exerciseAcquired | +2,000 | $87.92 | +$175,840 | 7,667 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −1,000 | $233.00 | −$233,000 | 6,667 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −1,000 | $232.00 | −$232,000 | 5,667 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseAcquired | +2,000 | $87.92 | +$175,840 | 7,667 | Direct | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −1,000 | $236.00 | −$236,000 | 6,667 | Direct | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −1,000 | $241.00 | −$241,000 | 5,667 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 19,200 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 17,200 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
*As attorney-in-fact for Reporting Person